A Study on the Policy Implication on the Management of Narcotics Distribution for Medical Use

의료용 마약류 유통 관리에 대한 고찰과 정책적 함의: 유통자료 및 청구자료 분석을 중심으로

  • Yu, Su-Yeon (Health Insurance Review and Assessment Service) ;
  • Cho, Hyunmin (Health Insurance Review and Assessment Service) ;
  • Kang, Hyeun Ah (Health Insurance Review and Assessment Service) ;
  • Kim, Sukyeong (National Evidence-based Healthcare Collaborating Agency)
  • 유수연 (건강보험심사평가원 심사평가연구소) ;
  • 조현민 (건강보험심사평가원 심사평가연구소) ;
  • 강현아 (건강보험심사평가원 심사평가연구소) ;
  • 김수경 (한국보건의료연구원)
  • Received : 2015.10.29
  • Accepted : 2015.12.07
  • Published : 2015.12.31

Abstract

Objectives: To suggest direction for improving policies by understanding current management of narcotics or psychotropic drugs and analyzing their distributions and usage. Method: We conducted a comparison analysis between health insurance claims and the amount supplied to health care institutions for narcotics or psychotropic drugs through health insurance claims data and drug distribution supply data from 2010 to 2012 collected from Korea Pharmaceutical Information Service Center (KPIS). Furthermore, we carried out literature investigation and online search to comprehend the current management of narcotics drugs in Korea. Results: The amount supplied to medical institutions for all drugs in 2012 was 19.4 trillion won, which increased from 19.5 trillion in 2011 by 0.54%. For narcotic drugs, the amount supplied was 318.4 billion won in 2011 and increased to 335.1 billion won by 5.3% in 2012, which exceeded the rate of increase for the amount supplied for all drugs. The proportion of amount claimed in the total amount supplied to medical institutions for all drugs was 60.5% in 2012, whereas the proportion of amount claimed for narcotic drugs was 55.6%, which showed that narcotic drugs were used relatively less within health insurance. Furthermore, management of the current domestic distribution supply data focuses on manufacturing and medical institution supply stages. Conclusion: Hereafter, the management of narcotics or psychotropic drugs needs to be improved by reinforcing active monitoring in optimal prescription and usage in patients by collecting and analyzing information on drug usage of patients.

Keywords

References

  1. Law on the control of Narcotics, ETC. Ministry of Health and Welfare. Korea. 2012.
  2. Kim IK, Choi L, Sohn KH, et al. A Study on the Management and the Prospect of Narcotic Reference Standards in Korea. Regul Res Food, Drug, Cosmet 2011;6(1):99-106.
  3. Kim HK. Legal Reform and Criminal Policy on Narcotics for Medical Use. Kor Inst Criminol 2006;12:13-178.
  4. Rah MS, Yoo BK. A descriptive research on drug use pattern of narcotic analgesics: a case of university hospital in Korea. Kor J Clin Pharm 2011;21(1):30-35.
  5. Article. Available at http://www.mfds.go.kr/daegu/index.do?mid=30&pageNo=2&cmd=v&seq=12999 (Accessed on January 20, 2013).
  6. Pharmaceutical products distribution information. Health Insurance Review and Assessment service. 2013
  7. Ministry of Food and Drug Safety, List of Narcotics. Available at http://ezdrug.mfds.go.kr/kfda2.2013 (Accessed on January 25, 2013).
  8. Pharmaceutical Affairs Act.2014.
  9. Park SS. Propofol Abuse and Efficient Management. Kor Assoc Addic Crim 2014;4(2):75-98.
  10. Kim SK, Yu SY, Kang HA, et al. RFID-based management of narcotics and psychotropic drugs. National IT Industry Promotion Agency. 2013.
  11. GS1 Healthcare reference book 2009/2010: 44-47. Available at http://www.gs1.org/docs/healthcare/GS1_Healthcare_Reference_Book_2009-2010.pdf (Accessed on December 7, 2015)
  12. Lee EG, Kang HH, Jang YJ, et al. Policy measures to ensure transparency and advancement of drug distribution. Ministry of Health and Welfare. 2007.
  13. Jung YT, Lee BG, Jung MJ, et al. A study on the development of pharmaceutical wholesalers industry. Korea Health Industry Development Institute. 2010.